Harbinger expanded its market reach by launching medium-duty electric and hybrid vehicle sales in Canada. Read more on Harbinger Motors →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
